Harry C. Lowe

ORCID: 0000-0001-5495-9717
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Valve Diseases and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiac Structural Anomalies and Repair
  • Peripheral Artery Disease Management
  • Cardiac Ischemia and Reperfusion
  • Cardiac, Anesthesia and Surgical Outcomes
  • Vascular Procedures and Complications
  • Cardiovascular Issues in Pregnancy
  • Angiogenesis and VEGF in Cancer
  • Cardiac and Coronary Surgery Techniques
  • Cardiovascular Function and Risk Factors
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Cardiac electrophysiology and arrhythmias
  • Advanced biosensing and bioanalysis techniques
  • Aortic aneurysm repair treatments
  • Atherosclerosis and Cardiovascular Diseases
  • Atrial Fibrillation Management and Outcomes
  • RNA Interference and Gene Delivery
  • Cardiac Arrest and Resuscitation
  • Cardiac Arrhythmias and Treatments
  • Signaling Pathways in Disease

Concord Repatriation General Hospital
2016-2025

Royal Prince Alfred Hospital
2006-2025

Western NSW Local Health District
2019-2025

The University of Sydney
2014-2024

Royal North Shore Hospital
2023

Concord Hospital
2003-2023

Florida Department of Health in Orange County
2023

Anzac Research Institute
2006-2015

Institute for Urban Indigenous Health
2015

GTx (United States)
2014

AimsWe investigated whether three-dimensional (3D) and two-dimensional quantitative coronary angiography (2D-QCA) measurements differed in their accuracy predicting reduced fractional flow reserve (FFR), how this varied with stenosis severity the FFR cut-off used.

10.1093/eurheartj/ehq259 article EN European Heart Journal 2010-08-12
Muthiah Vaduganathan Robert A. Harrington Gregg W. Stone Efthymios Deliargyris Philippe Gabríel Steg and 95 more C. Michael Gibson Christian W. Hamm Matthew J. Price Alberto Menozzi Jayne Prats Steven Elkin Kenneth W. Mahaffey Harvey D. White Deepak L. Bhatt Fernando Cura M Ballarino Aníbal Damonte Diego Grinfeld Carlos Alejandro Álvarez Alberto Ocaña A. Farshid Brendan Gunalingam Craig Jeurgens Harry C. Lowe H. Hallani G. Nelson Gishel New Ronald Dick Jeffrey Lefkovits Stephen W. Duffy Nick Bett Raibhan Yadav P. Garrahy Ron Lehman Philip E. Aylward John D. Horowitz M. Worthley D. Cross Jaime Rankin Peter Thompson Phil Roberts-Thomson D. Cross Rohan Jayasinghe Con Aroney Kurt Huber F Leisch Johann Altenberger Georg Gaul Thomas Neunteufl Franz Weidinger Herwig Schuchlenz H. Wéber Werner Benzer Paulo Roberto Ferreira ROSSI Breno Oliveira Almeida Antônio Francisco Godinho Fábio Vilas‐Boas Luciano Janussi Vacanti Renato Giestas Serpa José Antonio Jatene Gilmar Reis Jamil Abdalla Saad Marcos Maynar-Mariño Roberto Botelho Constantino Costantini Ricardo Wang Dalton Bertolim Précoma M Rati L. C. Bodanese Euler Roberto Fernandes Manenti João Paulo Zouvi Rogério Tumelero Arthur Herdy Eulógio Martinez Filho Antônio Carlos Carvalho Roberto Alexandre Franken Lawrence Title Charles Lazzam François Reeves Tamaz Shaburishvili Gulnara Chapidze Merab Mamatsashvili Irakli Khintibidze Kurt Huber Hans‐Georg Olbrich Sabine Genth‐Zotz S Moebius-Winkler Michael Buerke Stefan Hoffmann Peter W. Radke Helge Moellmann Hugo A. Katus HANS-FRIEDRICH VOEHRINGER Christian Hengstenberg Volker Klauß Johannes Brachmann Aftab Ahmad Khan Sampath Kumar P.P. Mohanan Praveen Chandra

10.1016/j.jacc.2016.10.055 article EN Journal of the American College of Cardiology 2017-01-01

Early growth response factor-1 (Egr-1) controls the expression of a growing number genes involved in pathogenesis atherosclerosis and postangioplasty restenosis. Egr-1 is activated by diverse proatherogenic stimuli. As such, this transcription factor represents key molecular target efforts to control vascular lesion formation humans. In study, we have generated DNAzymes targeting specific sequences human EGR-1 mRNA. These molecules cleave vitro transcribed mRNA efficiently at preselected...

10.1161/hh2001.097867 article EN Circulation Research 2001-10-12

Rapid access chest pain clinics (RACCs) are an innovative outpatient pathway that allows low-intermediate risk patients to avoid hospitalisation. However, the extent of RACCs in Australia is unknown. We aimed identify Australian and describe characteristics landscape this model care Australia. were identified through four pathways: 1) Systematic literature search; 2) Google Search; 3) Word mouth via RACC leaders including National Health Medical Research Council Translation Centres form...

10.1016/j.hlc.2024.12.006 article EN cc-by Heart Lung and Circulation 2025-05-01

Percutaneous transluminal coronary angioplasty is a frequently used interventional technique to reopen arteries that have narrowed because of atherosclerosis. Restenosis, or renarrowing the artery shortly after angioplasty, major limitation success procedure and due mainly smooth muscle cell accumulation in wall at site balloon injury. In present study, we demonstrate antiangiogenic sulfated oligosaccharide, PI-88, inhibits primary vascular proliferation reduces intimal thickening 14 days...

10.1161/01.res.0000071345.76095.07 article EN Circulation Research 2003-05-01

Animal models of cardiovascular pathology contribute towards understanding and treatment a broad range conditions. Specifically in the context acute myocardial infarction (AMI), rat have been commonly used studies pathogenesis, investigation novel therapies, although there has often difficulty translating experimental findings to clinical benefit. However, recent years seen two important changes our approaches AMI. First, is increasing recognition that pathophysiology human AMI process...

10.1160/th05-07-0514 article EN Thrombosis and Haemostasis 2006-01-01

Coronary reperfusion has been the mainstay therapy for reduced infarct size after a heart attack. However, this intervention also results in myocardial injury by initiating marked inflammatory reaction, and new treatments are keenly sought.The basic-region leucine zipper protein, c-Jun is poorly expressed normal myocardium induced within 24 hours ischemia-reperfusion injury. Synthetic catalytic DNA molecules (DNAzymes) targeting (Dz13) reduce area-at-risk (AAR) regardless of whether it...

10.1161/atvbaha.109.189753 article EN Arteriosclerosis Thrombosis and Vascular Biology 2009-07-11

Background Remote ischemic preconditioning (RIPC) attenuates myocardial damage during elective and primary percutaneous coronary intervention. Recent studies suggest that microcirculatory function is an important determinant of clinical outcome. The aim this study was to assess the effect RIPC on markers function. Methods Results Patients referred for cardiac catheterization fractional flow reserve measurement were randomized or sham. Operators patients blinded treatment allocation....

10.1161/jaha.118.009058 article EN cc-by-nc-nd Journal of the American Heart Association 2018-09-30
Coming Soon ...